Treprostinil Injection
Product Images NDC 0781-3430

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 0781-3430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Treprostinil Chemical Structure (Treprostinil Image 01)

Chemical structure of treprostinil showing the molecular arrangement and bonds of the active ingredient. The image also indicates the molecular formula C23H34O5 and molecular weight 390.52.*

FDA Label Image

Figure 1 (Treprostinil Image 02)

A Kaplan-Meier survival curve showing the percentage of patients without a clinical deterioration event over time in days. The graph compares Treprostinil Injection versus Placebo, with Treprostinil showing a higher rate of patients without clinical deterioration. The p-value is also shown as 0.000228, indicating statistical significance.*

FDA Label Image

20mg-carton (Treprostinil Image 03)

Box label for Treprostinil Injection 20 mg/20 mL (1 mg/mL), a sterile multi-dose vial intended for subcutaneous or intravenous infusion. The label displays the product name, strength, volume, and dosage form, with Sandoz Inc as the distributor. Storage instructions and a brief ingredient list are also included alongside barcodes and NDC number 0781-3420-80.*

FDA Label Image

50mg-carton (Treprostinil Image 04)

Packaging label for Treprostinil Injection 50 mg/20 mL (2.5 mg/mL) by Sandoz Inc, presented as a 20 mL multi-dose vial. Label specifies use for subcutaneous or intravenous infusion only, lists inactive ingredients, storage instructions, and cautions. Includes NDC 0781-3425-80 and barcode details.*

FDA Label Image

100mg-carton (Treprostinil Image 05)

Packaging label for Treprostinil Injection 100 mg/20 mL (5 mg/mL) by Sandoz Inc. The label indicates a 20 mL multi-dose vial for subcutaneous or intravenous infusion. It includes storage instructions, concentration details, and cautions such as 'Rx Only' and 'Keep out of reach of children.' The label also lists inactive ingredients and specifies sterile content.*

FDA Label Image

200mg-carton (Treprostinil Image 06)

Packaging label for Treprostinil Injection 200 mg/20 mL (10 mg/mL) by Sandoz Inc. The sterile, multi-dose vial of 20 mL is for subcutaneous or intravenous infusion only. The label includes ingredients and storage instructions at 20° to 25°C, and prominently displays the product name, strength, dosage form, route, and labeler information.*

FDA Label Image

Diluent-carton (Treprostinil Image 07)

Packaging label for Sterile Diluent for Treprostinil Injection, intended for intravenous infusion of treprostinil. The label states the product contains drug diluent and includes one 50 mL single-dose vial. The labeler is Sandoz Inc, with storage instructions to keep between 20° to 25°C and a warning not to freeze. The label includes a barcode and manufacturer details from Lek Pharmaceuticals d.d.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.